Headline Expenditure Projections
Pharmaceuticals: EUR44.31bn (USD59.38bn) in 2014 to EUR44.49bn (USD48.94bn) in 2015; 0.4% in local currency terms and -17.6% in US dollar terms. Forecast revised upwards from last quarter.
Healthcare: EUR317.55bn (USD425.51bn) in 2014 to EUR326.18bn (USD358.80bn) in 2015; +2.7% in local currency terms and -15.7% in US dollar terms. Forecast broadly in line with last quarter.
Full Report Details at
- http://www.fastmr.com/prod/1038249_germany_pharmaceuticals.aspx?afid=301
Risk/Reward Index
In Q415 Germany retains a RRI score of 69.2 out of 100 after a downward revision in H115. Germany remains ranked as the fourth most attractive market to pharmaceutical investors out of 15 markets in the Western Europe region in our RRI matrix. While high market expenditure indices and risks scores are illustrative of the country's relative attractiveness and favourable operating environment, potential industry rewards are capped by increasingly burdensome reimbursement and pricing regulation.
Key Trends and Developments
July 2015
Ireland-based generic drugmaker Perrigo signed an agreement to purchase Germany-based Naturwohl Pharma, along with its dietary supplement brand, Yokebe. The second-largest dietary brand in Germany in terms of market share, Yokebe comes in a shake/liquid form and is distributed within the 'meal replacement' category. The brand is estimated to generate net sales of about EUR30mn (USD32.9mn) in 2015.
June 2015
The Germany Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.
BMI's Germany Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Germany pharmaceutical and healthcare industry.
Key Benefits
* Benchmark BMI's pharmaceutical and healthcare market forecasts for Germany, to test other views - a key input for successful budgeting and strategic business planning in the German pharmaceutical and healthcare market.
* Target business opportunities and risks in the German pharmaceutical and healthcare sector
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)
You may also be interested in these related reports:
- Romania Pharmaceuticals & Healthcare Report Q4 2015
- Bulgaria Pharmaceuticals & Healthcare Report Q4 2015
- Peru Pharmaceuticals & Healthcare Report Q4 2015
- Latvia Pharmaceuticals & Healthcare Report Q4 2015
- Nigeria Pharmaceuticals & Healthcare Report Q4 2015